Seven Eight Capital, LP Horizon Therapeutics Public LTD CO Transaction History

Seven Eight Capital, LP

  • $927 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 06, 2020
SELL
$30.2 - $56.98 $392,600 - $740,740
-13,000 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$24.87 - $38.56 $323,310 - $501,280
13,000 New
13,000 $385,000
Q4 2019

Feb 13, 2020
SELL
$25.43 - $36.67 $1.4 Million - $2.02 Million
-55,020 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$23.0 - $27.97 $1.27 Million - $1.54 Million
55,020 New
55,020 $1.5 Million

Others Institutions Holding HZNP

# of Institutions
39
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email